Pharmacological Therapies: Addressing Unmet Needs in Refractory Celiac Disease and Market Opportunities
Refractory celiac disease (RCD), a severe form where GFD fails to resolve symptoms, affects up to 5% of patients and represents a critical unmet need in the celiac treatment market. Current options for RCD are limited—including steroids and immunosuppressants with significant side effects—leaving patients and clinicians eager for safer, more effective therapies. Emerging...
0 Comentários 0 Compartilhamentos 598 Visualizações 0 Anterior